Referências

1. Abernethy, M.G., Rosenfeld, A., White, J.R., Mueller, M.G., Lewicky-Gaupp, C., Kenton, K., Urinary microbiome and cytokine levels in women with interstitial cystitis (2017) Obstetrics and Gynecology, 129 (3), pp. 500-506
2. Abrams, P., Cardozo, L., Fall, M., Griffiths, D., Rosier, P., Ulmsten, U., Wein, A., The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the international continence society (2002) American Journal of Obstetrics and Gynecology, 187 (1), pp. 116-126
3. Bradley, M.S., Burke, E.E., Grenier, C., Amundsen, C.L., Murphy, S.K., Siddiqui, N.Y., A genome-scale DNA methylation study in women with interstitial cystitis/bladder pain syndrome (2018) Neurourology and Urodynamics, 37 (4), pp. 1485-1493
4. Braundmeier-Fleming, A., Russell, N.T., Yang, W., Nas, M.Y., Yaggie, R.E., Berry, M., Klumpp, D.J., Stool-based biomarkers of interstitial cystitis/bladder pain syndrome (2016) Scientific Reports, 6, p. 26083
5. Buzzega, D., Maccari, F., Galeotti, F., Volpi, N., Determination of urinary hexosamines for diagnosis of bladder pain syndrome (2012) International Urogynecology Journal, 23 (10), pp. 1367-1372
6. Byrne, D.S., Sedor, J.F., Estojak, J., Fitzpatrick, K.J., Chiura, A.N., Mulholland, S.G., The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis (1999) The Journal of Urology, 161 (6), pp. 1786-1790
7. Chai, T.C., Zhang, C.O., Shoenfelt, J.L., Johnson, H.W., Jr., Warren, J.W., Keay, S., Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis (2000) The Journal of Urology, 163 (5), pp. 1440-1444
8. Choi, D., Han, J.Y., Shin, J.H., Ryu, C.M., Yu, H.Y., Kim, A., Choo, M.S., Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion (2018) Scientific Reports, 8 (1)
9. Chung, S.D., Liu, H.T., Lin, H., Kuo, H.C., Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder (2011) Neurourology and Urodynamics, 30 (3), pp. 417-420
10. Coelho, A., Oliveira, R., Antunes-Lopes, T., Cruz, C.D., Partners in crime: NGF and BDNF in visceral dysfunction (2019) Current Neuropharmacology, 17 (11), pp. 1021-1038
11. Corcoran, A.T., Yoshimura, N., Tyagi, V., Jacobs, B., Leng, W., Tyagi, P., Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens (2013) World Journal of Urology, 31 (1), pp. 241-246
12. Duh, K., Funaro, M.G., DeGouveia, W., Bahlani, S., Pappas, D., Najjar, S., Stern, J.N.H., Crosstalk between the immune system and neural pathways in interstitial cystitis/bladder pain syndrome (2018) Discovery Medicine, 25 (139), pp. 243-250
13. El-Mansoury, M., Boucher, W., Sant, G.R., Theoharides, T.C., Increased urine histamine and methylhistamine in interstitial cystitis (1994) The Journal of Urology, 152 (2), pp. 350-353
14. Erickson, D.R., Xie, S.X., Bhavanandan, V.P., Wheeler, M.A., Hurst, R.E., Demers, L.M., Keay, S.K., A comparison of multiple urine markers for interstitial cystitis (2002) The Journal of Urology, 167 (6), pp. 2461-2469
15. Evans, R.J., Moldwin, R.M., Cossons, N., Darekar, A., Mills, I.W., Scholfield, D., Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis (2011) The Journal of Urology, 185 (5), pp. 1716-1721
16. Felsen, D., Frye, S., Trimble, L.A., Bavendam, T.G., Parsons, C.L., Sim, Y., Vaughan, E.D., Jr., Inflammatory mediator profile in urine and bladder wash fluid of patients with interstitial cystitis (1994) The Journal of Urology, 152 (2), pp. 355-361
17. Gamper, M., Viereck, V., Eberhard, J., Binder, J., Moll, C., Welter, J., Moser, R., Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C (2013) International Urogynecology Journal, 24 (12), pp. 2049-2057
18. Goo, Y.A., Tsai, Y.S., Liu, A.Y., Goodlett, D.R., Yang, C.C., Urinary proteomics evaluation in interstitial cystitis/painful bladder syndrome: A pilot study (2010) International Brazilian Journal of Urology, 36 (4), pp. 464-478. , discussion 478-469, 479
19. Grover, S., Srivastava, A., Lee, R., Tewari, A.K., Te, A.E., Role of inflammation in bladder function and interstitial cystitis (2011) Therapeutic Advances in Urology, 3 (1), pp. 19-33
20. Hanno, P.M., Interstitial cystitis-epidemiology, diagnostic criteria, clinical markers (2002) Revista de Urología, 1, pp. S3-S8. , 4 Suppl
21. Hanno, P.M., Erickson, D., Moldwin, R., Faraday, M.M., Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment (2015) The Journal of Urology, 193 (5), pp. 1545-1553
22. Hauser, P.J., Dozmorov, M.G., Bane, B.L., Slobodov, G., Culkin, D.J., Hurst, R.E., Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis (2008) The Journal of Urology, 179 (2), pp. 764-769
23. Homma, Y., Nomiya, A., Tagaya, M., Oyama, T., Takagaki, K., Nishimatsu, H., Igawa, Y., Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis (2013) The Journal of Urology, 190 (5), pp. 1925-1931
24. Hurst, R.E., Roy, J.B., Min, K.W., Veltri, R.W., Marley, G., Patton, K., Parsons, C.L., A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis (1996) Urology, 48 (5), pp. 817-821
25. Jiang, Y.H., Peng, C.H., Liu, H.T., Kuo, H.C., Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome (2013) PLoS One, 8 (10). , e76779
26. Keay, S., Kleinberg, M., Zhang, C.O., Hise, M.K., Warren, J.W., Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production (2000) The Journal of Urology, 164 (6), pp. 2112-2118
27. Keay, S., Zhang, C.O., Kagen, D.I., Hise, M.K., Jacobs, S.C., Hebel, J.R., Warren, J.W., Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls (1997) The Journal of Urology, 158 (5), pp. 1983-1988
28. Keay, S.K., Zhang, C.O., Shoenfelt, J., Erickson, D.R., Whitmore, K., Warren, J.W., Chai, T., Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis (2001) Urology, 57 (6), pp. 9-14
29. Kiuchi, H., Tsujimura, A., Takao, T., Yamamoto, K., Nakayama, J., Miyagawa, Y., Okuyama, A., Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: Its association with pain severity and glomerulations (2009) BJU International, 104 (6), pp. 826-831. , (discussion 831)
30. Kuo, H.C., Liu, H.T., Tyagi, P., Chancellor, M.B., Urinary nerve growth factor levels in urinary tract diseases with or without frequency urgency symptoms (2010) Low Urinary Tract Symptoms, 2 (2), pp. 88-94
31. Lamale, L.M., Lutgendorf, S.K., Zimmerman, M.B., Kreder, K.J., Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis (2006) Urology, 68 (4), pp. 702-706
32. Lee, C.L., Jiang, Y.H., Kuo, H.C., Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: A comparison with non-ulcerative interstitial cystitis and controls (2013) BJU International, 112 (8), pp. 1156-1162
33. Lee, J.D., Lee, M.H., Increased expression of hypoxia-inducible factor-1α and vascular endothelial growth factor associated with glomerulation formation in patients with interstitial cystitis (2011) Urology, 78 (4). , 971.e11-5
34. Liu, H.T., Kuo, H.C., Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease (2012) PLoS One, 7 (9). , e44687
35. Liu, H.T., Shie, J.H., Chen, S.H., Wang, Y.S., Kuo, H.C., Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome (2012) Urology, 80 (1). , 225.e213-8
36. Liu, H.T., Tyagi, P., Chancellor, M.B., Kuo, H.C., Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment (2009) BJU International, 104 (10), pp. 1476-1481
37. Liu, H.T., Tyagi, P., Chancellor, M.B., Kuo, H.C., Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity (2010) BJU International, 106 (11), pp. 1681-1685
38. Lokeshwar, V.B., Selzer, M.G., Cerwinka, W.H., Gomez, M.F., Kester, R.R., Bejany, D.E., Gousse, A.E., Urinary uronate and sulfated glycosaminoglycan levels: Markers for interstitial cystitis severity (2005) The Journal of Urology, 174 (1), pp. 344-349
39. Lotz, M., Villiger, P., Hugli, T., Koziol, J., Zuraw, B.L., Interleukin-6 and interstitial cystitis (1994) The Journal of Urology, 152 (3), pp. 869-873
40. Lowe, E.M., Anand, P., Terenghi, G., Williams-Chestnut, R.E., Sinicropi, D.V., Osborne, J.L., Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis (1997) British Journal of Urology, 79 (4), pp. 572-577
41. Magalhaes, T.F., Baracat, E.C., Doumouchtsis, S.K., Haddad, J.M., Biomarkers in the diagnosis and symptom assessment of patients with bladder pain syndrome: A systematic review (2019) International Urogynecology Journal, 30 (11), pp. 1785-1794
42. Makino, T., Kawashima, H., Konishi, H., Nakatani, T., Kiyama, H., Elevated urinary levels and urothelial expression of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein in patients with interstitial cystitis (2010) Urology, 75 (4), pp. 933-937
43. Marcu, I., Campian, E.C., Tu, F.F., Interstitial cystitis/bladder pain syndrome (2018) Seminars in Reproductive Medicine, 36 (2), pp. 123-135
44. Ogawa, T., Homma, T., Igawa, Y., Seki, S., Ishizuka, O., Imamura, T., Nishizawa, O., CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis (2010) The Journal of Urology, 183 (3), pp. 1206-1212
45. Pape, J., Falconi, G., De Mattos Lourenco, T.R., Doumouchtsis, S.K., Betschart, C., Variations in bladder pain syndrome/interstitial cystitis (IC) definitions, pathogenesis, diagnostics and treatment: A systematic review and evaluation of national and international guidelines (2019) International Urogynecology Journal, 30 (11), pp. 1795-1805
46. Parker, K.S., Crowley, J.R., Stephens-Shields, A.J., van Bokhoven, A., Lucia, M.S., Lai, H.H., Henderson, J.P., Urinary metabolomics identifies a molecular correlate of interstitial cystitis/bladder pain syndrome in a multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network cohort (2016) eBioMedicine, 7, pp. 167-174
47. Patnaik, S.S., Lagana, A.S., Vitale, S.G., Buttice, S., Noventa, M., Gizzo, S., Dandolu, V., Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome (2017) Archives of Gynecology and Obstetrics, 295 (6), pp. 1341-1359
48. Peeker, R., Enerbäck, L., Fall, M., Aldenborg, F., Recruitment, distribution and phenotypes of mast cells in interstitial cystitis (2000) The Journal of Urology, 163 (3), pp. 1009-1015
49. Peng, C.H., Jhang, J.F., Shie, J.H., Kuo, H.C., Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis- -clinical results and immunohistochemistry analysis (2013) Urology, 82 (6). , 1452.e1451-6
50. Peters, K.M., Diokno, A.C., Steinert, B.W., Preliminary study on urinary cytokine levels in interstitial cystitis: Does intravesical bacille Calmette-Guérin treat interstitial cystitis by altering the immune profile in the bladder? (1999) Urology, 54 (3), pp. 450-453
51. Rofeim, O., Shupp-Byrne, D., Mulholland, G.S., Moldwin, R.M., The effects of hydrodistention on bladder surface mucin (2001) Urology, 57 (6), p. 130
52. Shahid, M., Gull, N., Yeon, A., Cho, E., Bae, J., Yoon, H.S., Kim, J., Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A (2018) Scientific Reports, 8 (1), p. 4505
53. Shie, J.H., Kuo, H.C., Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome (2011) BJU International, 108 (2), pp. E136-E141
54. Slobodov, G., Feloney, M., Gran, C., Kyker, K.D., Hurst, R.E., Culkin, D.J., Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis (2004) The Journal of Urology, 171 (4), pp. 1554-1558
55. Tamaki, M., Saito, R., Ogawa, O., Yoshimura, N., Ueda, T., Possible mechanisms inducing glomerulations in interstitial cystitis: Relationship between endoscopic findings and expression of angiogenic growth factors (2004) The Journal of Urology, 172 (3), pp. 945-948
56. Tonyali, S., Ates, D., Akbiyik, F., Kankaya, D., Baydar, D., Ergen, A., Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis (2018) Advances in Clinical and Experimental Medicine, 27 (2), pp. 159-163
57. Tseng-Rogenski, S., Liebert, M., Interleukin-8 is essential for normal urothelial cell survival (2009) American Journal of Physiology. Renal Physiology, 297 (3), pp. F816-F821
58. Tyagi, P., Killinger, K., Tyagi, V., Nirmal, J., Chancellor, M., Peters, K.M., Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis (2012) The Journal of Urology, 187 (6), pp. 2243-2248
59. van de Merwe, J.P., Nordling, J., Bouchelouche, P., Bouchelouche, K., Cervigni, M., Daha, L.K., Wyndaele, J.J., Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: An ESSIC proposal (2008) European Urology, 53 (1), pp. 60-67
60. Van der Aa, F., Beckley, I., de Ridder, D., Polyomavirus BK—a potential new therapeutic target for painful bladder syndrome/interstitial cystitis? (2014) Medical Hypotheses, 83 (3), pp. 317-320
61. Vera, P.L., Preston, D.M., Moldwin, R.M., Erickson, D.R., Mowlazadeh, B., Ma, F., Fall, M., Elevated urine levels of macrophage migration inhibitory factor in inflammatory bladder conditions: A potential biomarker for a subgroup of interstitial cystitis/bladder pain syndrome patients (2018) Urology, 116, pp. 55-62
62. Wada, N., Ameda, K., Furuno, T., Okada, H., Date, I., Kakizaki, H., Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis (2015) The Journal of Urology, 193 (6), pp. 1987-1993
63. Wen, H., Lee, T., You, S., Park, S.H., Song, H., Eilber, K.S., Kim, J., Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkers (2015) Journal of Proteome Research, 14 (1), pp. 541-548
64. Zeng, Y., Wu, X.X., Homma, Y., Yoshimura, N., Iwaki, H., Kageyama, S., Kakehi, Y., Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis (2007) The Journal of Urology, 178 (4), pp. 1322-1327. , (discussion 1327)
65. Zhang, C.O., Li, Z.L., Kong, C.Z., APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis (2005) BMC Urology, 5, p. 7
66. Zhang, C.O., Li, Z.L., Shoenfelt, J.L., Kong, C.Z., Chai, T.C., Erickson, D.R., Keay, S., Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis (2003) Urology, 61 (5), pp. 897-901